Adenoid Cystic Carcinoma patient tells her story
Adenoid Cystic Carcinoma (ACC) is a very rare salivary gland cancer and hard to treat that mainly affects females. Belinda Charlton-Gilfoyle told her story recently to Sunday magazine about the struggle to get a diagnosis for her persistent and excruciating facial pain.
Oracle are funding a four year PhD research project under the supervision of Dr Amanda Swain to understand ACC and discover new treatments to support patients like Belinda.
Read Belinda’s story here:
Oracle funded research into ACC
Oracle is proud to be funding an project at the Institute of Cancer Research looking into new therapeutic options for ACC.
We have also agreed to fund a second project taking place at Brunel University London, also focused on improving survival of patients with ACC. See New treatment options for Adenoid Cystic Carcinoma.
World Radiotherapy Awareness Day 14th November
WRAD2025 has 250+ global organisations united for a crucial cause in radiotherapy best practice
Big #Cancer52 Conversation
Insightful discussions at the Big #Cancer52 Conversation focusing on reducing health inequalities.
National cancer plan
Government committed to a stand-alone cancer strategy and the importance of a national cancer plan.
£70m funding for radiotherapy
The recent announcement of £70 million in government funding for modern radiotherapy is welcome news
Rising rates of head and neck cancers in England
A new report from the University of Sheffield that highlights rising rates of head and neck cancer in England.
Research – Small Grants Programme opportunity
Small Grants Programme, offering a total funding £55,000 to support 1-3 innovative research projects.
Today is World Mental Health Day 💚
A head and neck cancer diagnosis can take a significant emotional toll, not only on the patient but also on their loved ones.